we are talking about ranbaxy. that's right. clearly, shares were rising in that region, but sun pharma agreed to by ranbaxy at $4.1 billion. here,sting, the movement the japanese company owning a large part of ranbaxy. >> it is a done deal essentially? >> yes. in 2008, the company bought ranbaxy for for for $1 billion. with u.s.ssues authorities. it has been a problem child. ranbaxy, for plans that didn't pass muster with the u.s. authorities. >> the fda, the food and drug administration in the states, ranbaxy had to recall some batches of its generic cholesterol-lowering drugs. that is a concern clearly. it is not good for the image. , and indian company, is agreeing to by ranbaxy. ranbaxy shares soared last week 26%. encouraging for earnings. it will become the fifth biggest speciality generic drug company in the world. they must deal with this u.s. issue. that is a concern. japan's third-biggest drug company -- they bought it back in november 2008. it give them a foothold in the generic space. there have to be some alarm bel

. >> last week, ranbaxy rose 26%. today, the ag sankyo which bought it back in 2008 is one of the for -- one of the few gainers on the naked 225, up 4.5%. so that is clearly a market thumbs-up on this deal. they are selling a $4 billion all-stop bill. all-stock deal. they did not meet standards of the faa -- of the fda. there is an fda cloud hanging over it. daiichi also has the fda hanging over one of its units. ranbaxy already knows about the situation. perhaps that helps ease the path. it becomes the fifth biggest generic drug maker in the world and the biggest pharma in india. -- a huge population. >> the hope is that they get over those as well. that is exactly what we have in prospect possibly. openlls are beginning to in india 45-week election that some observers say is the most important in more than 30 years. live pictures now as the world's biggest election gets underway. someone in mumbai. a very big day, a very big month in fact. what is at stake? india, aa big day for big day for the world's biggest democ

acquire ranbaxy.n pharma in it is buying ranbaxy to become the biggest from us -- pharma company in india. you will remember that ranbaxy, late last year, was the target of an fda rejection of some of its generic drugs being produced in the u.s. facing similar concerns as the u.s. banned some imports from sun pharma late last month. it has dragged on for weeks. tensions between students and lawmakers in taiwan have remained high. there has been a minor breakthrough. david inglis is here with the latest. what is the breakthrough? >> we had the speaker of the taiwan legislature come out and appear to have given them the biggest gesture to reach out and bridge what has been major differences over the course of those protesters. they have been there for 21 days. what do we have exactly here? he announced that there would not be any review of the services pact with china, which sparked the latest round of protests, until an oversight mechanism is past and in place. in other words, there will be no ratifica

accounted for 40% of ranbaxy's revenue. now four out of five factories can't list it here. >>> and we have a mega deal in europe this morning. time for the global reports market. i saw this happening over the weekend. the two big cement companies. >> but i don't want to make a joke about the cement companies. >> are you worried about the long? >> i didn't say anything. cement companies, what do you think goes on in cement companies? >> mixing, building, home construction? >> maybe now that they are a big industrial company, but in the old days, cement companies meant something else. >> jimmy hoffa was there? no, no, waste management. >> i was thinking tra ining tra collection. >> ross westgate, you don't really have that there, do you? >> concrete boots. various bits of criminal figures are in various bits of infrastructure supporting. >> what do you think was in the foundation of those buildings? >> yeah, exactly. that's the sort of thing. though it all happens. everything all happens here happens there. all sorts of thing

india's sun pharmaceuticals is buying its rival also india based generic drugmakers ranbaxy in an all-stock deal for just over $3 billion. both companies make many of the lower priced generics sold here in the u.s. >> closer to home, pfizer reported positive results from its latest trial of an experimental breast cancer drug by doubled the lifetime of patients on the medication. but survival rates were not significantly better. pfizer shares ended 3% lower, that made them the biggest decliner in the dow today. joining us now with more on this new drug is damian conover. he's the director of pharma research at morningstar. welcome good to see you. what is the name of the drug? who is it for? and what did the trial show? >> the drug is palbociclib and i think it's pfizer's most important product in their pipeline. and it's targeting a special subset of the breast cancer population. and right now the subset really doesn't have a lot of good treatment options. and what this drug showed was almost a double the benefit in progression-free survival. now that's an important end point that is a posi

buying ranbaxy labs. they expect $250 million in by the third year after completion of the deal.t is the biggest by an indian company in two years. india at ap, crossroads. we bring you up to speed on an election that will shape the fate of a country for decades to come. 800 million people are expected to vote. ♪ >> good morning, everybody. welcome back. you are watching "the pulse". india starts going to the polls today in the biggest democratic exercise in history. with a population of 1.2 billion, india's selections are set to last for five whole weeks. ryan chilcote looks at the staggering numbers. worlds largest democracy and this is the world's largest election. 815 million voters, more than every man, woman, and child in all of north america and europe. they will be casting their ballots in nine rounds of voting over the next five weeks at 8 million polling stations equipped with almost 2 million electronic voting machines. their job is to choose more than 500 lawmakers and the party that will run the world's 10th largest economy. countrywins rules a that is home to almost

india's largest drugmaker -- drugmaker agreed to by ranbaxy laboratories. they make generic drugs.xpect $250 million in revenue and reduced cost by the third year after completion of the deal. microsoft is going hollywood with a cast of comedians including sarah silverman and seth green. at are involved in shows microsoft's new television studio. , the superhero sequel to the 2011 movie, generated $96 million in its weekend debut. for walt disney, the figure is a record. welcome back. this is "countdown." >> time in london is 17 minutes past seven. we just had earnings from good energy group, an alternative to the big six as they are known. joining us now to talk about those numbers is the chief executive officer. thank you very much for coming in. as ank about your sector alternative to the big six energy suppliers. how big can this oh? >> we have seen our own growth go up more than double in the last year. i think we can see this sector -- we are now producing around 30% of the uk's renewable electricity. we are seeing significant growth. i think this can continue. >> could brita